Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The ANZCTR website will be unavailable from 1pm until 3pm (AEDT) on Wednesday the 30th of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial registered on ANZCTR
Registration number
ACTRN12610000987066
Ethics application status
Approved
Date submitted
29/10/2010
Date registered
16/11/2010
Date last updated
8/11/2016
Type of registration
Retrospectively registered
Titles & IDs
Public title
STroke imAging Prevention and Treatment (START): PrePARE Prediction and Prevention to Achieve optimal Recovery Endpoints after stroke
Query!
Scientific title
STroke imAging Prevention and Treatment (START): PrePARE Prediction and Prevention to Achieve optimal Recovery Endpoints after stroke
Query!
Secondary ID [1]
252755
0
Protocol No: NTA0902
Query!
Universal Trial Number (UTN)
Query!
Trial acronym
START_PrePARE
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
Stroke
258254
0
Query!
Depression
258255
0
Query!
Cognition
258256
0
Query!
Condition category
Condition code
Stroke
258448
258448
0
0
Query!
Ischaemic
Query!
Physical Medicine / Rehabilitation
258543
258543
0
0
Query!
Occupational therapy
Query!
Mental Health
258544
258544
0
0
Query!
Depression
Query!
Intervention/exposure
Study type
Observational
Query!
Patient registry
Query!
Target follow-up duration
Query!
Target follow-up type
Query!
Description of intervention(s) / exposure
The START_PrePARE study is an observational cohort study that is part of the START program of study. In addition it will be linked as a sub-study of the START _EXTEND study, ACTRN: 12610000011088, which is a randomised, multicentre, double blinded, placebo controlled phase 3 trial within a larger cohort study of ischaemic stroke patients. Blood biomarkers, lesion location, and diet and lifestyle factors will be investigated in relation to post-stroke depression and functional outcome in the total START cohort, including START-EXTEND (up to n = 200). In START-PrePARE we will investigate the relationship between advanced imaging (resting state activity, cortical thickness and fibre tract integrity) and functional outcome and depression over time in a cohort of 100 patients. Assessments will include:
Biomarker (blood sample) collection at baseline, Day3, 3 months and 12 months;
Neurological and functional assessment at Day 3-7, 3 months and 12 months: NIHSS, mRS and BI;
Cognition at Day 3-7, 3 months and 12 months: Montreal Cognitive Assessment;
Diet and Lifestyle questionnaires at Day 3-7, 3 months and 12 months: Cancer Council of Victoria diet questionnaire, Rapid Assessment of Physical Activity questionnaire;
Depression at Day 3-7, 3 months and 12 months; (Montgomery-Asberg Depression Rating Scale with non-verbal supports if necessary);
Advanced brain imaging at 3 and 12 months;
Functional status at 3 and 12 months: Cognition (Mini Mental State Examination, Trails-B, Digit span, Shape Cancellation Task, Raven Colored Progressive Matrices, Stroop test), and Sensorimotor (Action Research Arm Test, Tactile Discrimination Test, Timed up and go test);
Participation at 3 and 12 months: Activity Card Sort-Aus
Quality of Life at 3 and 12 months: Stroke Impact Scale and Work and Social Adjustment Scale;
Mortality and recurrent stroke at 3 and 12 months.
Query!
Intervention code [1]
257271
0
Not applicable
Query!
Comparator / control treatment
Not applicable
Query!
Control group
Uncontrolled
Query!
Outcomes
Primary outcome [1]
259282
0
Functional and structural changes in the brain: i.e cortical thickness, fibre tract connection and functional resting-state connections.
Query!
Assessment method [1]
259282
0
Query!
Timepoint [1]
259282
0
3 and 12 months
Query!
Primary outcome [2]
259283
0
Depression (Montgomery-Asberg Depression Rating Scale with non-verbal supports)
Query!
Assessment method [2]
259283
0
Query!
Timepoint [2]
259283
0
3 and 12 months
Query!
Primary outcome [3]
259284
0
Functional status: Functional Independence (mRS), Cognition (MoCA, MMSE, Trails-B, Digit span, Shape Cancellation Task, RCPM, Stroop test), and Sensorimotor (Action Research Arm Test, Tactile Discrimination Test, Timed up and go test)
Query!
Assessment method [3]
259284
0
Query!
Timepoint [3]
259284
0
3 and 12 months
Query!
Secondary outcome [1]
265905
0
Participation (Activity Card Sort)
Query!
Assessment method [1]
265905
0
Query!
Timepoint [1]
265905
0
3 and 12 months
Query!
Secondary outcome [2]
265906
0
Quality of life (Stroke Impact Scale)
Query!
Assessment method [2]
265906
0
Query!
Timepoint [2]
265906
0
3 and 12 months
Query!
Secondary outcome [3]
265907
0
Mortality and recurrent stroke
Query!
Assessment method [3]
265907
0
Query!
Timepoint [3]
265907
0
3 and 12 months
Query!
Eligibility
Key inclusion criteria
1. Patients presenting with ischaemic stroke.
2. Patient, family member or legally responsible person depending on local ethics requirements has given informed consent for participation in the START_PrePARE study
3. Patient’s age is > 18 years.
Query!
Minimum age
18
Years
Query!
Query!
Maximum age
No limit
Query!
Query!
Sex
Both males and females
Query!
Can healthy volunteers participate?
No
Query!
Key exclusion criteria
1. Patients who are non-English speaking
2. Contraindication to MR imaging on 3Tesla scanner.
3. Pre-stroke MRS score of greater or equal to 2 (indicating previous disability)
4. Any terminal illness such that the patient would not be expected to survive more than 1 year.
5. Pregnant women (clinically evident)
Query!
Study design
Purpose
Natural history
Query!
Duration
Longitudinal
Query!
Selection
Convenience sample
Query!
Timing
Prospective
Query!
Statistical methods / analysis
Query!
Recruitment
Recruitment status
Completed
Query!
Date of first participant enrolment
Anticipated
21/06/2010
Query!
Actual
21/06/2010
Query!
Date of last participant enrolment
Anticipated
Query!
Actual
13/04/2015
Query!
Date of last data collection
Anticipated
Query!
Actual
13/04/2015
Query!
Sample size
Target
100
Query!
Accrual to date
Query!
Final
100
Query!
Recruitment in Australia
Recruitment state(s)
VIC
Query!
Recruitment hospital [1]
2153
0
Western Hospital - Footscray
Query!
Recruitment hospital [2]
2154
0
Epworth Richmond - Richmond
Query!
Recruitment hospital [3]
6899
0
Royal Melbourne Hospital - City campus - Parkville
Query!
Recruitment hospital [4]
6900
0
Austin Health - Austin Hospital - Heidelberg
Query!
Recruitment hospital [5]
6901
0
Monash Medical Centre - Clayton campus - Clayton
Query!
Recruitment postcode(s) [1]
7828
0
3011 - Footscray
Query!
Recruitment postcode(s) [2]
7829
0
3121 - Richmond
Query!
Recruitment postcode(s) [3]
14567
0
3050 - Parkville
Query!
Recruitment postcode(s) [4]
14568
0
3084 - Heidelberg
Query!
Recruitment postcode(s) [5]
14569
0
3168 - Clayton
Query!
Funding & Sponsors
Funding source category [1]
257816
0
Government body
Query!
Name [1]
257816
0
Commonwealth Scientific and Industrial Research Organisations (CSIRO)
Query!
Address [1]
257816
0
Locked Bag 10
Clayton South VIC 3169
Query!
Country [1]
257816
0
Australia
Query!
Primary sponsor type
Other Collaborative groups
Query!
Name
National Stroke Research Institute (NSRI)
Query!
Address
Melbourne Brain Centre, 245 Burgundy Street, Heidelberg, Victoria, 3084
Query!
Country
Australia
Query!
Secondary sponsor category [1]
257020
0
None
Query!
Name [1]
257020
0
Query!
Address [1]
257020
0
Query!
Country [1]
257020
0
Query!
Other collaborator category [1]
251551
0
Other Collaborative groups
Query!
Name [1]
251551
0
Brain Research Institute
Query!
Address [1]
251551
0
Melbourne Brain Centre, 245 Burgundy Street, Heidelberg, 3084
Query!
Country [1]
251551
0
Australia
Query!
Other collaborator category [2]
251552
0
University
Query!
Name [2]
251552
0
University of Melbourne
Query!
Address [2]
251552
0
The University of Melbourne
Grattan Street
Victoria 3010
Query!
Country [2]
251552
0
Australia
Query!
Ethics approval
Ethics application status
Approved
Query!
Ethics committee name [1]
259840
0
Melbourne Health Human Research Ethics Committee
Query!
Ethics committee address [1]
259840
0
Office for Research Level 6 East, Main Building The Royal Melbourne Hospital 300 Grattan St Parkville Victoria 3050
Query!
Ethics committee country [1]
259840
0
Australia
Query!
Date submitted for ethics approval [1]
259840
0
Query!
Approval date [1]
259840
0
13/01/2010
Query!
Ethics approval number [1]
259840
0
2009.079
Query!
Ethics committee name [2]
259841
0
Austin Health Human Research Ethics Committee
Query!
Ethics committee address [2]
259841
0
Henry Buck Building Austin Hospital 145 Studley Road Heidelberg Victoria, 3084
Query!
Ethics committee country [2]
259841
0
Australia
Query!
Date submitted for ethics approval [2]
259841
0
Query!
Approval date [2]
259841
0
06/01/2010
Query!
Ethics approval number [2]
259841
0
H2010/03588
Query!
Ethics committee name [3]
296283
0
Epworth HealthCare Human Research and Ethics Committee
Query!
Ethics committee address [3]
296283
0
Bridge Road, Richmind 3121
Query!
Ethics committee country [3]
296283
0
Australia
Query!
Date submitted for ethics approval [3]
296283
0
Query!
Approval date [3]
296283
0
25/07/2012
Query!
Ethics approval number [3]
296283
0
54812
Query!
Ethics committee name [4]
296284
0
La Trobe University Human Ethics Committee
Query!
Ethics committee address [4]
296284
0
Bundoora, 3086
Query!
Ethics committee country [4]
296284
0
Australia
Query!
Date submitted for ethics approval [4]
296284
0
Query!
Approval date [4]
296284
0
19/09/2010
Query!
Ethics approval number [4]
296284
0
10-071
Query!
Ethics committee name [5]
296285
0
Monash Medical Centre, Southern Health Research Governance
Query!
Ethics committee address [5]
296285
0
246 Clayton Road, Clayton 3168
Query!
Ethics committee country [5]
296285
0
Australia
Query!
Date submitted for ethics approval [5]
296285
0
Query!
Approval date [5]
296285
0
14/12/2010
Query!
Ethics approval number [5]
296285
0
HREC/10/MH/76 SSA/10/SHB/22
Query!
Ethics committee name [6]
296286
0
Western Health Office for Research
Query!
Ethics committee address [6]
296286
0
Furlong Rd, St Albans, 3021
Query!
Ethics committee country [6]
296286
0
Australia
Query!
Date submitted for ethics approval [6]
296286
0
Query!
Approval date [6]
296286
0
28/02/2011
Query!
Ethics approval number [6]
296286
0
HREC/10/MH/76 2009.079
Query!
Summary
Brief summary
Stroke and depression are two of the highest ranked diseases in the Burden of Disease rankings of the World Health Organisation. Depression is a common sequela of stroke, with recent estimates between 30-60% of all stroke patients. Depression after stroke is often under diagnosed despite the fact that effective treatment exists. Good predictors of depression that could be used to identify ‘at risk’ patients early as part of the clinical care pathway for stroke currently do not exist. This study aims to investigate the association between poststroke depression and 1) novel imaging markers of brain structure and function as identified by specialized MRI, and 2)functional outcomes including cognition, mood, sensorimotor function, and participation in daily activities. START-PrePARE is an observational cohort study that is part of the START program of study. In addition it will be linked as a sub-study of the START-EXTEND study (NTA 0901), which is a randomised, multicentre, double blinded, placebo controlled phase 3 trial within a larger cohort study of ischaemic stroke patients. START-PrePARE will comprise 100 patients. Participants consented onto the START-PrePARE study will be seen at their hospital at baseline, Day 3-7, 3 months and 12 months for collection of bloods and a series of research tests investigating mood, thinking ability (cognition), diet and lifestyle. The patients will also travel to a central site in Melbourne (the Melbourne Brain Centre), at 3 month and 12 month time points. Here advanced MR imaging, plus more advanced clinical measures of mood, cognition, sensori-motor function and participation will be performed. Investigators and patients will remain blinded to START-EXTEND treatment designation. At Baseline a blood sample will be taken, two brief neurological assessments will be conducted and a medical history will be obtained. 3-7 days following stroke, participants will have another blood test, one brief neurological assessment and three questionnaires conducted asking about their diet and lifestyle and their mood and cognition. At the 3 month and 12 month visits participants will have specialised brain MRI scans which will approximately take 40 minutes plus set up time. They will also be given 10 short assessment tasks and three questionnaires to measure functional outcomes including cognition, mood, and movement as well as participation in household, leisure and social activities and quality of life. These assessments will be administered by a qualified therapist, and will take approximately 120 minutes. The blood test and neurological assessments will be conducted at hospital and the 10 short tasks will be conducted at the Melbourne Brain Centre or at the participant's place of residence if more convenient. All information collected will be recorded without any identifying information and kept private and confidential. An independent Data Safety Monitoring Committee has been set up to monitor safety for START-PrePARE patients for the duration of the trial.
Query!
Trial website
www.csiro.start.com
Query!
Trial related presentations / publications
Ma H, Parsons MW, Christensen S, Campbell BCV, Churilov L, Connelly A, et al. (2012)A multicentre, randomized, double-blinded, placebo-controlled Phase III study to investigate EXtending the time for Thrombolysis in Emergency Neurological Deficits (EXTEND). Int J Stroke 7, 74-80 Tse, T., Douglas, J., Lentin, P., Linden, T., Churilov, L., & Carey, L. M. (2014). Reduced activity participation 3 months after stroke associated with increased levels of depressive symptoms and stroke severity: An observational cohort study. Paper presented at the Stroke Society of Australasia 25th ASM, Hamilton Island, 30th July – 1st August. Int J Stroke 2014:9(Supp 1)21. doi:10.111/ijs.12297 Yusoff, S. Z. B., Tse, T., Carey, L. M. (2015). Factors impacting Quality of Life in stroke survivors at 3 and 12 months post-stroke: A longitudinal study of an Australian stroke cohort. International Journal of Stroke, 10(Suppl 3): 29-29. Carey, L. M., Crewther, S., Salvado, O., Linden, T., Connelly, A., Wilson, W., Tse, T et al. (2015). STroke imAging pRevention and treatment (START): A longitudinal stroke cohort study: Clinical trials protocol. International Journal of Stroke, 10(4), 636-644. doi: 10.1111/ijs.12190 Palmer SM, Crewther SG, Carey LM and The START Project Team (2015) A meta-analysis of changes in brain activity in clinical depression. Front. Hum. Neurosci. 8:1045. doi: 10.3389/fnhum.2014.01045 Nguyen, V. A., Carey, L. C., Giummarra, L., Faou, P., Cooke, I., Howells, D. W., Tse, T., Macaulay, L., Ma, H., Davis, S. M., Donnan, G. A., Crewther, S. G. (accepted 23/05/2016). A Pathway Proteomic Profile of Ischemic Stroke Survivors Reveals Innate Immune Dysfunction in Association with Mild Symptoms of Depression - A Pilot Study. Frontiers in Neurology. Tse, T. and L. M. Carey (2016). Longitudinal changes in activity participation after mild stroke. Asia Pacific Stroke Conference combined with Stroke Society of Australasia. Brisbane, Queensland, Australia, Cerebrovascular Diseases. Tse, T. and L. M. Carey (2016). The Activity Card Sort – Australia: Validation and reliability in an Australian stroke cohort. Asia Pacific Stroke Conference combined with Stroke Society of Australasia. Brisbane, Queensland, Australia, Cerebrovascular Diseases. Nguyen, V. A., Carey, L. C., Giummarra, L,. Faou, P., Cooke, I., Howells, D. W., Tse, T., Macaulay, L., Ma, H., Davis, S. M., Donnan, G. A., Crewther, S. G. (2016). A Pathway Proteomic Profile of Ischemic Stroke Survivors Reveals Innate Immune Dysfunction in Association with Mild Symptoms of Depression - A Pilot Study. Asia Pacific Stroke Conference combined with Stroke Society of Australasia. Brisbane, Queensland, Australia, Cerebrovascular Disease
Query!
Public notes
Query!
Contacts
Principal investigator
Name
31689
0
Prof Leeanne Carey
Query!
Address
31689
0
Melbourne Brain Centre, 245 Burgundy Street, Heidelberg, Vic, 3084
Query!
Country
31689
0
Australia
Query!
Phone
31689
0
+61 3 9035 7088
Query!
Fax
31689
0
Query!
Email
31689
0
[email protected]
Query!
Contact person for public queries
Name
14936
0
Elise Cowley
Query!
Address
14936
0
Melbourne Brain Centre, 245 Burgundy Street, Heidelberg, 3084
Query!
Country
14936
0
Australia
Query!
Phone
14936
0
+61 3 90357232
Query!
Fax
14936
0
+61 3 9496 2881
Query!
Email
14936
0
[email protected]
Query!
Contact person for scientific queries
Name
5864
0
Leeanne Carey
Query!
Address
5864
0
Melbourne Brain Centre, 245 Burgundy Street, Heidelberg, 3084
Query!
Country
5864
0
Australia
Query!
Phone
5864
0
+61 3 90357088
Query!
Fax
5864
0
+61 3 90357303
Query!
Email
5864
0
[email protected]
Query!
No information has been provided regarding IPD availability
What supporting documents are/will be available?
No Supporting Document Provided
Results publications and other study-related documents
Documents added manually
No documents have been uploaded by study researchers.
Documents added automatically
Source
Title
Year of Publication
DOI
Embase
Comparing Participation Outcome Over Time Across International Stroke Cohorts: Outcomes and Methods.
2019
https://dx.doi.org/10.1016/j.apmr.2019.05.025
Embase
Longitudinal changes in activity participation in the first year post-stroke and association with depressive symptoms.
2019
https://dx.doi.org/10.1080/09638288.2018.1471742
N.B. These documents automatically identified may not have been verified by the study sponsor.
Download to PDF